Revolution Medicines (RVMD) revenue

Revenue · fiscal 2023
$11.58M

Revolution Medicines (RVMD) reported revenue of $11.58M in fiscal 2023 (the year ended December 31, 2023). That is 67.3% lower than the $35.38M of fiscal 2022. Figures as of 18 Nov 2026, 09:50 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2023
$11.58M
Change on fiscal 2022
−67.3%
Growth, 5 years
−10.5% a year
Highest on record
$50.04Mfiscal 2019
Lowest on record
$11.58Mfiscal 2023
Fiscal years on record
62018–2023

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revolution Medicines revenue, in more detail

Over the five fiscal years to 2023 revenue shrank at a compound 10.5% a year. Across the 6 fiscal years on record (2018–2023), the highest was $50.04M in fiscal 2019 and the lowest $11.58M in fiscal 2023.

History · 6 fiscal years

Revenue by fiscal year

Revolution Medicines revenue, year by year

Revolution Medicines (RVMD) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2023$11.58M 67.3% down
2022$35.38M 20.4% up
2021$29.39M 31.6% down
2020$42.98M 14.1% down
2019$50.04M 148.2% up
2018$20.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Revolution Medicines and comparable companies
CompanyRevenueFiscal year
BeOne Medicines ONC$5.34B2025
Waters WAT$3.17B2025
Natera NTRA$2.31B2025
IQVIA Holdings IQV$16.31B2025
Revolution Medicines RVMD$11.58M2023
Royalty Pharma RPRX$2.38B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines revenue: questions and answers

What is Revolution Medicines's revenue?

Revolution Medicines (RVMD) reported revenue of $11.58M in fiscal 2023 (the year ended December 31, 2023). That is 67.3% lower than the $35.38M of fiscal 2022.

What is the growth rate of Revolution Medicines's revenue?

Over the five fiscal years to 2023 revenue shrank at a compound 10.5% a year.

What are the highest and lowest revenue figures on record for Revolution Medicines?

Across the 6 fiscal years on record (2018–2023), the highest was $50.04M in fiscal 2019 and the lowest $11.58M in fiscal 2023.

How is Revolution Medicines's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Revolution Medicines it is on record here for 6 fiscal years, 2018 to 2023.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/RVMD/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.